Search research articles
Contact Us
Filters
Showing results (41-50 of 211) with videos related to
Page
of 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2017
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma
Morihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, et al.
Experimental Hematology
|
March 8, 2002
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications
Yu-Tzu Tai, Klaus Podar, Stine-Kathrein Kraeft, et al.
British Journal of Haematology
|
May 20, 2003
Recombinant humanized anti-CD40 monoclonal antibody triggers autologous antibody-dependent cell-mediated cytotoxicity against multiple myeloma cells
Toshiaki Hayashi, Steven P Treon, Teru Hideshima, et al.
Blood
|
July 16, 2016
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
Gang An, Chirag Acharya, Xiaoyan Feng, et al.
Experimental Hematology
|
June 26, 2007
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model
Laurence Catley, Teru Hideshima, Dharminder Chauhan, et al.
Blood
|
August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications
Daisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Blood
|
February 25, 2016
MUC1-C drives MYC in multiple myeloma
Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.
Blood
|
September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
Ze Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Cancer Research
|
October 20, 2004
Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib
Klaus Podar, Reshma Shringarpure, Yu-Tzu Tai, et al.
Nature Communications
|
May 2, 2018
Widespread intronic polyadenylation diversifies immune cell transcriptomes
Irtisha Singh, Shih-Han Lee, Adam S Sperling, et al.
Page
of 22
Search research articles
Search
Showing results (41-50 of 211) with videos related to
Sort By:
Page
of 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2017
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma
Morihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, et al.
Experimental Hematology
|
March 8, 2002
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications
Yu-Tzu Tai, Klaus Podar, Stine-Kathrein Kraeft, et al.
British Journal of Haematology
|
May 20, 2003
Recombinant humanized anti-CD40 monoclonal antibody triggers autologous antibody-dependent cell-mediated cytotoxicity against multiple myeloma cells
Toshiaki Hayashi, Steven P Treon, Teru Hideshima, et al.
Blood
|
July 16, 2016
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
Gang An, Chirag Acharya, Xiaoyan Feng, et al.
Experimental Hematology
|
June 26, 2007
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model
Laurence Catley, Teru Hideshima, Dharminder Chauhan, et al.
Blood
|
August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications
Daisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Blood
|
February 25, 2016
MUC1-C drives MYC in multiple myeloma
Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.
Blood
|
September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
Ze Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Cancer Research
|
October 20, 2004
Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib
Klaus Podar, Reshma Shringarpure, Yu-Tzu Tai, et al.
Nature Communications
|
May 2, 2018
Widespread intronic polyadenylation diversifies immune cell transcriptomes
Irtisha Singh, Shih-Han Lee, Adam S Sperling, et al.
Page
of 22